中国肿瘤临床与康复
中國腫瘤臨床與康複
중국종류림상여강복
CHINESE JOURNAL OF CLINICAL ONCOLOGY AND REHABILITATION
2001年
1期
94-95
,共2页
谢印法%于竹成%李玲%薛德文%张慧芳%梁超前
謝印法%于竹成%李玲%薛德文%張慧芳%樑超前
사인법%우죽성%리령%설덕문%장혜방%량초전
晚期贲门癌%介入治疗%栓塞%放疗
晚期賁門癌%介入治療%栓塞%放療
만기분문암%개입치료%전새%방료
目的探讨晚期贲门癌的胃左动脉化疗栓塞、外放射综合治疗的方法。方法先行胃左动脉插管超选化疗栓塞,药物为CF300mg、5-Fu 1000~1500mg、CDDP60~80mg、MMC10~20mg与40%碘化油5~8ml 混悬液。介入化疗栓塞后或两次介入之间行放疗。结果 21例患者完全缓解(CR )8例(38.1%),部分缓解(PR)11例(52.3%),总有效率(CR+PR)90.4%。6个月、1年、3年存活率为85.7%,52.3%,33.3%。结论介入结合放疗治疗晚期贲门癌不失为临床选用的治疗手段。
目的探討晚期賁門癌的胃左動脈化療栓塞、外放射綜閤治療的方法。方法先行胃左動脈插管超選化療栓塞,藥物為CF300mg、5-Fu 1000~1500mg、CDDP60~80mg、MMC10~20mg與40%碘化油5~8ml 混懸液。介入化療栓塞後或兩次介入之間行放療。結果 21例患者完全緩解(CR )8例(38.1%),部分緩解(PR)11例(52.3%),總有效率(CR+PR)90.4%。6箇月、1年、3年存活率為85.7%,52.3%,33.3%。結論介入結閤放療治療晚期賁門癌不失為臨床選用的治療手段。
목적탐토만기분문암적위좌동맥화료전새、외방사종합치료적방법。방법선행위좌동맥삽관초선화료전새,약물위CF300mg、5-Fu 1000~1500mg、CDDP60~80mg、MMC10~20mg여40%전화유5~8ml 혼현액。개입화료전새후혹량차개입지간행방료。결과 21례환자완전완해(CR )8례(38.1%),부분완해(PR)11례(52.3%),총유효솔(CR+PR)90.4%。6개월、1년、3년존활솔위85.7%,52.3%,33.3%。결론개입결합방료치료만기분문암불실위림상선용적치료수단。
Objective To study the combined therapy of left g astric artery chemoembolization and external irradiation for advanced cardia can ce r.Methods The first step was superselective left gastric artery chemotherapy with CF300mg,5-Fu1000~1500mg,CDDP60~80mg,followed by emblizatio n with MMC lipidol suspension.After the chemoembolization, radiotherapy was carr i ed out.Results The whole effective rate was 90.4%(CR 8 and PR 1 1),the six-month、one-year、three-year survival rate was 85.7%,52.3%,33.3%. respectively.Conclusions The combinded therapy is effective on advance cardia cancer.